Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Iovance Biotherapeutics Inc (NQ: IOVA )

4.550 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1
Open 4.550
Bid (Size) 4.600 (9)
Ask (Size) 4.800 (2)
Prev. Close 4.550
Today's Range 4.550 - 4.550
52wk Range 4.360 - 10.41
Shares Outstanding 247,776,653
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Iovance Biotherapeutics to Present Clinical and Pre-Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapies at Society for Tumor Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
Four-year Analysis of C-144-01 Trial Cohorts 2 and 4 
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire

Performance

YTD
-25.53%
-25.53%
1 Month
-26.02%
-26.02%
3 Month
-35.92%
-35.92%
6 Month
-27.55%
-27.55%
1 Year
-51.28%
-51.28%

More News

Read More
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Shares of Iovance Biotherapeutics Jumped Monday
Via The Motley Fool
Where Iovance Biotherapeutics Stands With Analysts
Via Benzinga
Expert Ratings for Iovance Biotherapeutics
Via Benzinga
Why Nikola Shares Are Trading Higher By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Over $26M Bet On This Biotechnology Stock? Check Out These 4 Stocks Insiders Are Buying
Via Benzinga
Alteryx, Iovance Biotherapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Via Benzinga
Why Iovance Biotherapeutics Stock Rocketed 13% Higher Today
Via The Motley Fool
Personalized Skin Cancer Therapy, Despite FDA Delay: Analysts Show Confidence In Iovance Biotherapeutics Therapy
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Nasdaq Down Over 1%; US Industrial Output Rises In August
Via Benzinga
Topics Stocks
Exposures US Equities
Iovance Biotherapeutics Inc. (NASDAQ: IOVA) is One of Friday Morning’s Most Active Stocks
Via Investor Brand Network
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Volcon Shares Are Trading Lower By 19%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Mitek Systems, Arm Holdings And Other Big Stocks Moving Higher In Friday's Pre-Market Session
Via Benzinga
U.S. Food and Drug Administration Updates Prescription Drug User Fee Act (PDUFA) Action Date for Lifileucel for the Treatment of Advanced Melanoma
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Why Shares of Iovance Biotherapeutics Dropped Thursday
Via The Motley Fool
Why Clearmind Medicine Shares Are Trading Lower By 53%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Iovance Biotherapeutics Stock Is Down 15%: What's Going On?
Via Benzinga
Iovance Biotherapeutics to Present at 2023 Wells Fargo Healthcare Conference
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List
Via InvestorPlace
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.